BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 18, 2003
View Archived Issues
CytRx Raises $8.7M, Forms Subsidiary For RNAi Efforts
Raising $8.7 million in a private placement, CytRx Corp. said it's using most of the money to form a subsidiary that will develop orally active small-molecule RNA interference drugs for obesity and Type II diabetes. (BioWorld Today)
Read More
Repligen, BMS Receive Patent Ruling; More Trouble Ahead?
Read More
South Koreans Reveal 3-D Structure Of Viagra Active Site - Drug Design With Better Pharmacological Profile
Read More
Aphton Raises $22.7M, Plans FDA Filing For Cancer Drug
Read More
ICAAC
Read More
Other News To Note
Read More